3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Pyxis Oncology closed an underwritten public offering on October 1, 2026, selling 36,047,919 shares and pre-funded warrants for 1,883,121 shares, each paired with common warrants, for a combined price of $2.90 per share. The company expects net proceeds of about $102.8 million, and says its cash plus these proceeds will fund operations into the first half of 2028. The common warrants cannot be exercised until stockholders approve an increase in authorized shares, and if they are exercised, the company would receive about $162.2 million more, net of a 6% solicitation fee.
Offering: 36,047,919 shares and 1,883,121 pre-funded warrants, with common warrants for up to 49,310,352 shares; closed October 1, 2026
Combined public offering price of $2.90 per share; common warrants have a $3.50 exercise price
Net proceeds of about $102.8 million; up to about $162.2 million more if all warrants are exercised, net of a 6% fee
Warrants require a stockholder vote to increase authorized shares, with a meeting planned within 60 days of closing; the company says funds may be insufficient for the Phase 3 Headliner trial if warrants go unexercised
Nexalin Technology received Nasdaq confirmation on September 30, 2026 that it has regained compliance with the $1.00 minimum bid price requirement. The company still must show at least $2,500,000 in stockholders' equity by January 4, 2027, or its stock faces delisting from Nasdaq.
Nasdaq confirmed on September 30, 2026 that the bid price requirement of $1.00 per share is met
Remaining condition: stockholders' equity of at least $2,500,000 by January 4, 2027
The company says it intends to meet the equity requirement, but gives no assurance it will
On October 1, 2026, subsidiary 5E SVM completed its purchase of real property, production facilities, brine resources and other assets from Searles Valley Minerals and related sellers. Consideration included about $3.4 million in cash, 8.3 million common shares and a $6.2 million promissory note, and 5E SVM also took a $10.0 million senior secured bridge loan from Karnavati Holdings, of which $7.0 million was funded at closing. The deal adds assets and debt and increases the share count, which shareholders will want to track.
Consideration: about $3.4 million cash (including a prior deposit), 8.3 million common shares (including 312,500 shares due later upon conditions) and a $6.2 million senior unsecured promissory note.
Promissory note accrues 14.5% annual interest, paid in kind; requires a cash payment of about $1.2 million at the 24-month anniversary and matures on the fifth anniversary.
$10.0 million senior secured bridge facility with Karnavati Holdings, 8.00% interest paid in kind, $7.0 million funded at closing, matures 270 days after closing with a $1.0 million fee.
Shares outstanding after closing: 49,634,871. Company expects $15.7 million cash as of September 30, 2026; the filing gives post-transaction cash as $19.6 with no unit, and Q3 results are preliminary.
Goodyear approved a plan on September 29, 2026 to close its chemical manufacturing facilities in Niagara Falls, New York and Bayport, Texas, affecting about 85 jobs. The company estimates total pre-tax charges of $55 million to $75 million, with about $30 million in cash charges, and expects the plan to improve Americas segment operating income by $15 million to $20 million annually starting in 2027.
Plant closures: Niagara Falls, New York and Bayport, Texas; about 85 job reductions
Estimated pre-tax charges of $55 million to $75 million, of which about $30 million are cash charges
Approximately $35 million of charges expected in Q3 2026 and $15 million in the rest of 2026
Expected annual Americas operating income benefit of $15 million to $20 million beginning in 2027
La Rosa Holdings Corp. (Nasdaq: LRHC) acquired NVIDIA B300 GPUs, leased them back under a long-term arrangement, and said it will evaluate strategic alternatives for its real estate operations, including a potential divestiture. The filing also issues Series F preferred stock in several transactions with conversion into common stock, which could dilute shareholders, and names Nicholas Adler CEO effective October 1, 2026. The filing is from La Rosa Holdings Corp., not Stratum Holdings Corp. (SRTM) as named in the request.
Sept. 28, 2026 Exchange Agreement: holders exchanged $1,500,000 of an $11,000,000 senior secured convertible note, plus all Series C, D and E preferred shares, for 3,410 Series F preferred shares.
Sept. 30, 2026 Settlement Agreement: 500 Series F shares issued for $5,688,263 in outstanding tokens; 5,500 more are due if conditions are met.
Sept. 30, 2026 Contribution and Purchase Agreement: 3,000 Series F shares issued for contributed GPUs; 4,000 more are due after $350,000 of gross rental income, and up to 25,000 additional shares may be issued.
Nicholas Adler became CEO and interim CFO effective October 1, 2026; founder Joe La Rosa stepped down as CEO and remains a director.
Aptera Motors said it now estimates it needs about $25 million to reach start of production, down from $40 million to $45 million, and about $115 million for its full high-volume plan, down from $180 million to $205 million. The company attributes the lower estimates mainly to its partnership with Shanghai Launch Automotive Technology, but all estimates depend on obtaining financing on acceptable terms and on a timely basis.
Start of production estimate: about $25 million, down from $40 million to $45 million (a reduction of about 38% to 44%)
Full-plan estimate: about $115 million, down from $180 million to $205 million; about $65 million to reach 500 vehicles per month
First 40 production vehicles planned to begin building by end of 2026, with initial customer deliveries in early 2027, subject to financing
Veritone agreed on September 30, 2026 to sell 20,000,000 shares of common stock to purchasers in a registered direct offering, with expected gross proceeds of $15.0 million before offering expenses. The company plans to use the net proceeds, together with existing cash, to repay or restructure part of its convertible debt and for working capital, and the forward-looking statements cite its 1.75% convertible senior notes due November 2026. The new shares add to the existing share count, while the filing says the proceeds are intended to address debt maturing later this year.
Issuance of 20,000,000 shares of common stock at $0.001 par value under an effective Form S-3 shelf registration
Expected gross proceeds of $15.0 million before offering expenses
Closing expected on or about October 2, 2026, subject to customary closing conditions
Proceeds intended to repay or restructure part of convertible debt, including 1.75% convertible senior notes due November 2026 referenced in the filing
McCormick reported third-quarter fiscal 2026 net sales up 17.4%, helped mainly by the McCormick de Mexico acquisition, with organic growth of 1.9%. Diluted EPS fell to $0.36 from $0.84 after $0.50 per share of special charges, while adjusted EPS was $0.86 versus $0.85 a year earlier. The company reaffirmed its fiscal 2026 outlook, though the special charges weigh on reported profit.
Net sales rose 17.4% in the quarter, with organic sales up 1.9% and McCormick de Mexico contributing 14.6%.
Reported operating income was $217 million versus $289 million a year earlier; adjusted operating income was $359 million versus $294 million.
Special charges lowered diluted EPS by $0.50, including a non-cash impairment of about $43.1 million tied to ending a pepper sourcing project in Malaysia.
The company reaffirmed its fiscal 2026 outlook, including adjusted EPS of $3.05 to $3.13, and said it remains on track for the proposed Unilever Foods combination, expected to close by mid-2027.
VisionWave and Sadot Group closed a Joint Venture and Operating Agreement on September 30, 2026, creating CMJV, a 50/50 vehicle that holds VisionWave's rights in C.M. Composite Materials, including about $7.81 million of advances to CM. Sadot committed to fund an equal $7,814,323 in cash over time, but the planned 51% CM acquisition remains conditional on a Belrise joint venture that has not been satisfied or waived, and VisionWave does not currently own any CM equity.
On September 30, 2026, VisionWave, Sadot Group and CMJV LLC signed the JV Agreement; the joint venture closed the same day.
VisionWave contributed its CM rights and about $7.81 million of advances to CMJV for 7,814,323 membership units; Sadot committed $7,814,323 in cash.
Sadot must fund its commitment in tranches, with $3.0 million due by December 30, 2026, and the full amount by September 30, 2027.
The Belrise Condition is unsatisfied; the outside closing date was extended to December 31, 2026, and VisionWave received 250,000 Sadot common shares.
On September 30, 2026, Sadot Group entered a joint venture agreement with VisionWave Holdings and formed CMJV LLC, a 50/50 vehicle tied to C.M. Composite Materials, an Israeli composites maker, and issued 250,000 common shares to VisionWave as an entry premium. The company must fund a capital commitment equal to $7,814,323 in tranches over twelve months, but the acquisition of C.M. has not closed and its key closing condition remains unmet, so the company's interest could be reduced if it does not fund in full.
The company must fund $7,814,323 in cash to CMJV in tranches, with a minimum of $3.0 million by December 30, 2026 and the full amount by September 30, 2027.
The 250,000 shares issued to VisionWave were about 17.2% of the 1,457,589 shares outstanding as of September 29, 2026.
The Belrise Condition has not been satisfied or waived; the outside closing date for the C.M. acquisition was extended to December 31, 2026.
Director Haggai Ravid sits on the VisionWave board; the company's other directors approved the transactions after disclosure of his relationship.
Inseego closed its acquisition of Nokia's Fixed Wireless Access business on October 1, 2026, issuing Nokia 1,163,693 shares, warrants and assumed liabilities as consideration, and Nokia made a $10 million cash investment in Inseego. Inseego says the deal is expected to approximately double its revenue, but the filing gives no revenue or profit figures, and Nokia's stake of about 11% plus warrants dilutes existing shareholders.
Acquisition completed October 1, 2026; first announced April 30, 2026.
Inseego issued 1,163,693 shares and Consideration Warrants to Nokia and assumed certain FWA Business liabilities.
Nokia received about 1.9 million shares (about 11% ownership) and warrants for up to about 0.8 million shares at $4.26 per share.
Nokia will pay Inseego a further $10 million in cash by October 15, 2026; about 250 people associated with the business will support Inseego's operations.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.